Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2007 | 09-2007 | 06-2007 | 03-2007 | 12-2006 | |
| Sales | 1,850 | 1,099 | 590 | 171 | 1,263 |
| Gross Profit | 1,850 | 1,099 | 590 | 171 | 1,120 |
| Operating Expenses | 7,351 | 6,766 | 5,648 | 5,418 | 5,900 |
| Operating Income | -5,501 | -5,667 | -5,058 | -5,247 | -4,637 |
| Interest Expense | 0 | 0 | 0 | 0 | 2 |
| Other Income | 261 | 116 | 97 | 571 | 229 |
| Pre-tax Income | -5,240 | -5,551 | -4,961 | -4,676 | -4,410 |
| Income Tax | N/A | N/A | N/A | N/A | -610 |
| Net Income Continuous | -5,240 | -5,551 | -4,961 | -4,676 | -4,274 |
| Net Income | $-5,240 | $-5,551 | $-4,961 | $-4,676 | $-4,274 |
| EPS Basic Total Ops | -1.68 | -1.68 | -1.50 | -1.44 | -1.44 |
| EPS Basic Continuous Ops | -1.61 | -1.71 | -1.53 | -1.44 | -1.50 |
| EPS Diluted Total Ops | -1.68 | -1.68 | -1.50 | -1.44 | -1.44 |
| EPS Diluted Continuous Ops | -1.61 | -1.71 | -1.53 | -1.44 | -1.50 |
| EBITDA(a) | $-5,417 | $-5,607 | $-5,013 | $-5,190 | $-4,107 |